by Regina Lynn Preciado | Apr 25, 2022
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines. One part of achieving that goal is to get content through regulatory approval faster. To speed up review and approval, pharma...
by Regina Lynn Preciado | Apr 11, 2022
“We cannot change the authoring experience.” This, more than anything else, is the message we used to be told (and still hear often) when we suggest a component-based structured authoring environment for medical writers at pharmaceutical companies. The authoring...
by Regina Lynn Preciado | Mar 28, 2022
The pharma industry is no stranger to standards. Pharmaceutical companies have entire teams devoted to ensuring that all data and content is collected, created, managed, retained, and retired according to regulatory requirements. Many of those legal requirements have...
by Regina Lynn Preciado | Feb 28, 2022
Using component-based structured content authoring and having a robust reuse strategy is the only way to produce pharma content at scale. It’s how you produce accurate content efficiently across the enterprise. It’s how you deliver the right content to the right place...
by Regina Lynn Preciado | Feb 21, 2022
The pharma industry has come together to develop technical solutions that speed time-consuming processes and reduce errors that can cause risk to the business and ultimately to patients. The goals of these technical solutions include: Facilitate digital information...
by Regina Lynn Preciado | Feb 14, 2022
We can no longer afford the costs of traditional, document-based content management in the pharmaceutical industry. We need pharma companies to prioritize content reuse and automation rather than manual, error-prone legacy processes. We do not need pharma companies...
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.